Percutaneous closure of patent foramen ovale: Impact of device design on safety and efficacy

Heart

Volumn 90, Issue 2, 2004, Pages 186-190

  Schwerzmann, M ^a   Windecker, S ^a   Wahl, A ^a   Mehta, H ^a   Nedeltchev, K ^b   Mattle, H ^b   Seiler, C ^a   Meier, B ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DEVICE; DIABETES MELLITUS; DYSLIPIDEMIA; EMBOLISM; FEMALE; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPERTENSION; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PARADOXICAL EMBOLISM; PREDICTION; PRIORITY JOURNAL; SAFETY; SMOKING; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 0742272738     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2002.003111     Document Type: Article

References (24)

1. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52.
2. Godart F, Rey C, Prat A, et al. Atrial right-to-left shunting causing severe hypoxaemia despite normal right-sided pressures. Report of 11 consecutive cases corrected by percutaneous closure. Eur Heart J 2000;21:483-9.
3. Bansal RC, Marsa RJ, Holland D, et al. Severe hypoxemia due to shunting through a patent foramen ovale: a correctable complication of right ventricular infarction. J Am Coll Cardiol 1985;5:188-92.
4. Amsel BJ, Rodrigus I, De Paep R, et al. Right-to-left flow through a patent foramen ovale in acute right ventricular infarction. Two case reports and a proposal for management. Chest 1995;108:1468-71.
5. Chevrolet JC, Junod AF. [Interauricular right-left shunt: a serious complication of primary pulmonary arterial hypertension]. Schweiz Med Wochenschr 1985;115:1348-50.
6. Wilmshurst PT, Byrne JC, Webb-Peploe MM. Relation between interatrial shunts and decompression sickness in divers. Lancet 1989;ii:1302-6.
7. Schwerzmann M, Seiler C, Lipp E, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 2001;134:21-4.
8. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998;8:327-30.
9. Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-51.
10. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-9.
11. Schuchlenz HW, Weihs W, Horner S, et al. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456-62.
12. De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-13.
13. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-6.
14. Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-8.
15. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-16.
16. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-8.
17. Wohl A, Meier B, Haxel B, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001;57:1330-2.
18. Han YM, Gu X, Titus JL, et al. New self-expanding patent foramen ovale occlusion device. Cathet Cardiovasc Intervent 1999;47:370-6.
19. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-9.
20. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996;46:1301-5.
21. Deorani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100:11171-5.
22. Ruchot P, Bogousslavsky J, Hurni M, et al. Systematic surgical closure of patent foramen ovale in selected patients with cerebrovascular events due to paradoxical embolism. Early results of a preliminary study. Eur J Cardiothorac Surg 1997;11:824-7.
23. Windecker S, Wahl A, Schwerzmann M, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale for secondary prevention of TIAs and strokes: a case-control study [abstract]. J Am Coll Cardiol 2002;39:265A.
24. Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 2002;105:2845-8.